Vaccine development and approval in Canada

Download the alternative format
(PDF format, 356 KB, 1 page)

Organization: Health Canada

Published: 2020-12-08

Vaccine development

Exploratory

Scientists develop a new vaccine.

Preclinical

Scientists conduct lab and animal studies before testing on humans.

Clinical Trials

Clinical trials

Phase I: 10s of volunteers

Phase II: 100s of volunteers

Phase III: 1000s of volunteers

Application

Manufacturer submits application to Health Canada for review.

Review and approval of vaccines

Scientific Review

Teams of Health Canada experts conduct a thorough and independent review of all vaccine data.

For COVID-19 vaccines, Health Canada is using a fast-tracked process that allows manufacturers to submit data as it becomes available, and for Health Canada experts to start the review process right away. Vaccines will only be authorized once we have all necessary evidence.

Approval

Health Canada approves a vaccine if it is safe, it works, it meets manufacturing standards, and the benefits outweigh the risks.

Distribution

Governments coordinate the purchase, logistics and distribution of vaccines across Canada.

Vaccination

All Canadians have access to the vaccine.

Ongoing Monitoring and Review

Continuous monitoring and review to confirm the safety of the vaccine, and that benefits outweigh risks.

Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: